From PCR to Portfolio: Christine Aylward is Funding Life Sciences

Christine Aylward is the founder and managing partner of Magnetic Ventures, a VC built on a thesis: the future of life sciences will be technology-driven. Her bet, placed in 2018, is paying off. Her path to venture capital is unique. She started at Roche, working on PCR, arguably the most revolutionary technology at the intersection of tech and life sciences in the last century. Then she co-founded a media company with Natalie Portman. Then she launched Magnetic, raising money for companies using machine learning to transform drug discovery, clinical trials, and more. Jim and Christine get into what it really takes to spot transformative science before it's obvious, why machine learning matters more than the word AI, and why the translation from technology to product is so hard.